Evoke (LON:EVOK) Trading Down 18.7% – Should You Sell?

Shares of Evoke plc (LON:EVOKGet Free Report) traded down 18.7% on Wednesday . The stock traded as low as GBX 56 ($0.72) and last traded at GBX 58.05 ($0.75). 55,595,465 shares traded hands during trading, an increase of 1,853% from the average session volume of 2,847,325 shares. The stock had previously closed at GBX 71.40 ($0.92).

Analysts Set New Price Targets

A number of research analysts recently issued reports on EVOK shares. Berenberg Bank lowered their target price on Evoke from GBX 130 ($1.68) to GBX 90 ($1.16) and set a “buy” rating on the stock in a report on Wednesday, December 4th. Jefferies Financial Group reiterated a “buy” rating and issued a GBX 140 ($1.81) target price on shares of Evoke in a report on Monday, December 16th.

View Our Latest Analysis on EVOK

Evoke Stock Performance

The firm has a market capitalization of £224.78 million, a P/E ratio of -1.26 and a beta of 0.84. The firm has a 50 day moving average price of GBX 68.88 and a two-hundred day moving average price of GBX 63.49.

Evoke (LON:EVOKGet Free Report) last released its quarterly earnings results on Wednesday, March 26th. The company reported GBX (6.40) (($0.08)) earnings per share for the quarter. Evoke had a negative net margin of 8.50% and a negative return on equity of 517.98%. Equities research analysts forecast that Evoke plc will post 12.7648305 earnings per share for the current fiscal year.

Insider Activity

In other Evoke news, insider Andrea Gisle Joosen purchased 14,572 shares of the company’s stock in a transaction that occurred on Tuesday, January 28th. The shares were purchased at an average cost of GBX 70 ($0.91) per share, with a total value of £10,200.40 ($13,202.69). Corporate insiders own 27.00% of the company’s stock.

About Evoke

(Get Free Report)

Featured Articles

Receive News & Ratings for Evoke Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evoke and related companies with MarketBeat.com's FREE daily email newsletter.